Establishing Manufacturing Controls : A Hurdle for the Cell and Gene Therapy Industry

In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society (2022)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,592

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Gene Therapy.Ruth Chadwick - 2009 - In Helga Kuhse & Peter Singer (eds.), A Companion to Bioethics. Oxford, UK: Wiley‐Blackwell. pp. 205–215.
Human somatic cell gene therapy.Arthur Bank - 1996 - Bioessays 18 (12):999-1007.
Somatic Cell Therapy: A Genetic Rescue for a Tattered Immune System?Bryn Williams-Jones - 2012 - BioéthiqueOnline 1:4.
Human gene therapy and slippery slope arguments.T. McGleenan - 1995 - Journal of Medical Ethics 21 (6):350-355.
Genetic Disorders and the Ethical Status of Germ-Line Gene Therapy.E. M. Berger & B. M. Gert - 1991 - Journal of Medicine and Philosophy 16 (6):667-683.
Human gene therapy and the slippery slope argument.Veikko Launis - 2002 - Medicine, Health Care and Philosophy 5 (2):169-179.
Gene Therapy and Germline Cells Research.Ferdinando A. Insanguine Mingarro - 2023 - In Erick Valdés & Juan Alberto Lecaros (eds.), Handbook of Bioethical Decisions. Volume I: Decisions at the Bench. Springer Verlag. pp. 79-99.
The lin‐12 locus of Caenorhabditis elegans.Iva Greenwald - 1987 - Bioessays 6 (2):70-73.
High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine.Frazer A. Tessema, Ameet Sarpatwari, Leah Z. Rand & Aaron S. Kesselheim - 2022 - Journal of Law, Medicine and Ethics 50 (2):380-384.
Gene Therapy for Neurological Disorders: New Therapies or Human Experimentation?P. R. Lowenstein - 2004 - In Justine Burley & John Harris (eds.), A Companion to Genethics. Oxford, UK: Blackwell. pp. 18–32.
Better Humans and evolutionary nudge.Ann Boyd - 2017 - Eubios Journal of Asian and International Bioethics 27 (4):116-120.
Ethical questions in human germ-line gene therapy.Imre Szebik - unknown
Ethical issues in and beyond prospective clinical trials of human Gene therapy.John C. Fletcher - 1985 - Journal of Medicine and Philosophy 10 (3):293-310.
Bench, bedside, boardroom: negotiating translational gene therapy.Courtney Addison - 2017 - New Genetics and Society 36 (1):22-42.
Who Benefits?— Why personal identity does not matter in a moral evaluation of germ‐line gene therapy.Nils Holtug & Peter Sandøe - 1996 - Journal of Applied Philosophy 13 (2):157-166.

Analytics

Added to PP
2023-12-24

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references